Inspire Investing’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31 Sell
1
-385
-100% -$10.9K ﹤0.01% 1264
2026
Q2
$11.9K Buy
386
+385
+38,500% +$9.5K ﹤0.01% 1114
2026
Q1
$26 Sell
1
-1
-50% -$22 ﹤0.01% 1090
2025
Q4
$45 Buy
+2
New +$41 ﹤0.01% 1080
2023
Q3
– Sell
-15,318
Closed -$311K – 867
2023
Q2
$311K Buy
15,318
+366
+2% +$6.97K 0.04% 766
2023
Q1
$273K Buy
14,952
+3,531
+31% +$67.5K 0.03% 633
2022
Q4
$236K Buy
11,421
+3,534
+45% +$97.2K 0.03% 458
2022
Q3
$206K Buy
+7,887
New +$209K 0.03% 654

Other funds holding RCUS

Inspire Investing's RCUS Position: Q3 2026 in Review

Inspire Investing reduced its Arcus Biosciences (RCUS) stake by 100% in Q3 2026, selling an estimated $10.9K and leaving 1 share worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #1264.

Inspire Investing first reported a position in RCUS in Q3 2022 and has held it in 8 quarters since. The position peaked at $311K in Q2 2023. 171 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

  • Inspire Investing held 1 share of Arcus Biosciences worth $31 as of Q3 2026.
  • Inspire Investing sold 385 Arcus Biosciences shares in Q3 2026, an estimated $10.9K.
  • Arcus Biosciences made up ﹤0.01% of Inspire Investing's portfolio in Q3 2026, its #1264 holding.
  • Inspire Investing first reported a position in Arcus Biosciences in Q3 2022 and has held it in 8 quarters since.
  • Inspire Investing's Arcus Biosciences position peaked at $311K in Q2 2023.
  • 171 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Inspire Investing's 13F filing for Q3 2026, filed 22 Oct 2026.